The Blinc Group And Think20 Labs Announce Research Partnership Focused On Cannabis Vaping Emissions

Vape Science

NEW YORK: The Blinc Group, the leading provider of customized vaping solutions for the Cannabis industry, and Think20 Labs, an analytical testing laboratory for Hemp and Cannabis, announced a research partnership. The objective of this research is to develop a vaping apparatus that helps identify possible dangerous compounds that are inhaled by consumers. More in-depth Read the full article…

First US Clinical Study Assessing Hemp-Derived Cannabinoid Supplementation In Recovery From Traumatic Brain Injury Begins In Colorado

medical marijuana

COLORADO:  The Flowering HOPE Foundation and Clover Leaf University have just announced sponsorship and collaboration on the first US clinical study to be approved to investigate plant-derived cannabinoid supplements in recovery from brain injury.  The study will analyze quantitative EEG brain activity and a cannabinoid-sensitive salivary biomarker in 40 subjects with mild traumatic brain injury and controls who currently Read the full article…

Study: Majority Of Medical Cannabis Patients Are Seeking Pain Relief

Kabunky

MICHIGAN: Most US patients registered to access medical cannabis cite chronic pain as their primary qualifying condition, according to data published in the journal Health Affairs. Investigators from the University of Michigan, Ann Arbor reviewed patient registration data from the majority of states that provide medical cannabis access. (Some states, notably California and Maine, possess voluntary registries and therefore Read the full article…

Medical Schools Including Cannabis Content In Their Curriculum

Medicine_aryballos_Louvre_CA1989-2183_n2

PENNSYLVANIA: A growing percentage of colleges of pharmacy are instituting medical cannabis training as part of their curriculum, according to survey data published in the journal Currents in Pharmacy Teaching and Learning. Researchers at the University of Pittsburgh contacted 140 US schools of pharmacy regarding whether they include medical cannabis-related topics in their curriculum. Among respondents, 62 percent reported Read the full article…

Case Report: Daily CBD Administration Associated With Remission Of Schizophrenic Symptoms

schizophrenic

GERMANY: The adjunctive use of cannabidiol is associated with a remission in schizophrenic symptoms in a patient previously unresponsive to conventional treatment, according to a case report published in the Australian & New Zealand Journal of Psychiatry. Investigators from the University of Leipzig in Germany assessed the use of twice-daily dosing of 750mg of CBD in conjunction with clozapine Read the full article…

Thousands Of Peer-Reviewed Studies Specific To Medical Cannabis Have Been Published Over Past Decade

Medical-Science

ISRAEL: The total number of peer-reviewed scientific papers dedicated to cannabis, and the therapeutic use of cannabis in particular, has increased exponentially in recent years, according to data published the journal Population Health Management. Israeli researchers assessed trends in the number of scientific publications specific to cannabis as compared to all scientific publications during the years 2000 to 2017. They reported: Read the full article…

Patients Frequently Turning To Cannabis To Treat Symptoms Of Sickle Cell Disease

finding that is consistent with reports from other cohorts of chronic pain patients.

CONNECTICUT: Medical cannabis use is relatively common among patients with sickle cell disease, according to survey data published in the journal Cannabis and Cannabinoid Research. Investigators at Yale University conducted an anonymous questionnaire among 58 patients with the disease. Forty-two percent of respondents reported having used cannabis within the past two years, and 31 percent reported having used it Read the full article…

Patients Dramatically Reduce Their Opioid Use Following Cannabis Access

MMJ reduces opioid use

CANADA: Pain patients enrolled in Canada’s legal medical cannabis access program significantly reduce their use of opioids over the long-term, according to longitudinal data provided by Tilray Canada Ltd - one of the nation’s largest, licensed provider of medicinal marijuana products. Investigators assessed opioid use patterns in a cohort of 573 patients using Tilray-provided products. Among those patients who acknowledged Read the full article…

Patients Use Fewer Opioids Following Enrollment In Medical Cannabis Program

MMJ

NEW YORK:  Patients enrolled in New York state’s medical cannabis program reduce their use of opioids and spend less money on prescription medications, according to data published online in the journal Mental Health Clinician. Investigators from GPI Clinical Research labs in Rochester and the University of Buffalo assessed trends in patients’ medical cannabis and prescription drug use following Read the full article…

Study: Cannabis Use Associated With Lower Risk Of Atrial Fibrillation Among Patients Hospitalized For Heart Failure

Cannabis Use Associated With Lower Risk Of Atrial Fibrillation Among Patients Hospitalized For Heart Failure

NEW YORK: Cannabis exposure is associated with lower instances of atrial fibrillation (arrhythmia) in patients hospitalized for heart failure, according to data published in the American Journal of Cardiology. A team of investigators from Seton Hall University, the University of Alabama at Birmingham, and elsewhere assessed the relationship between cannabis exposure and atrial fibrillation in a cohort of nearly four million Read the full article…